Molina Healthcare Reports Mixed Q4 and Year-End Financial Results for 2025
Molina Healthcare, Inc. (NYSE: MOH) has released its financial results for the fourth quarter and the full year of 2025, revealing a stark contrast between the company's performance in the most recent quarter and its overall achievements throughout the year. The report, disseminated on February 5, 2026, highlights significant developments in revenue, earnings, and operational metrics.
1. Fourth Quarter Performance
In the fourth quarter of 2025, Molina Healthcare reported a GAAP loss per diluted share of $3.15, a sharp decline compared to a diluted earnings per share of $4.44 during the same period in 2024. The adjusted loss per diluted share for Q4 2025 stood at $2.75, down from $5.05 in Q4 2024. This negative trend raises questions about the company's profitability in the short term.
Key Financial Metrics for Q4 2025
- Premium Revenue: $10,715 million, a 7.4% increase from $9,983 million in Q4 2024.
- Total Revenue: $11,375 million, up from $10,499 million in the previous year.
- Net (Loss) Income: ($160) million, compared to a profit of $251 million in Q4 2024.
- Medical Care Ratio (MCR): 94.6%, indicating an increase in healthcare costs relative to premiums earned, compared to 90.2% in Q4 2024.
- G&A Ratio: 7.0%, slightly higher than the 6.3% recorded a year ago.
- After-tax Margin: (1.4%), a decline from the 2.4% margin achieved in Q4 2024.
2. Year-End Financial Results
Despite the disappointing fourth quarter, Molina Healthcare's full year 2025 performance showcased a more favorable outlook. The company reported a GAAP earnings per diluted share of $8.92, down from $20.42 in 2024, but still reflecting the overall growth trajectory for the year.
Key Financial Metrics for Full Year 2025
- Premium Revenue: $43,052 million, a robust increase of 11.8% from $38,627 million in 2024.
- Total Revenue: $45,426 million, up from $40,650 million year-over-year.
- Net (Loss) Income: $472 million, significantly lower than the $1,179 million recorded in 2024.
- Adjusted Earnings per Diluted Share: $11.03, down from $22.65 in the previous year.
- Medical Care Ratio (MCR): 91.7%, indicating an increase in healthcare-related expenses compared to 89.1% in 2024.
- G&A Ratio: 6.6%, slightly improved from 6.7% in 2024.
- After-tax Margin: 1.0%, down from 2.9% in the prior year.
3. Analysis and Outlook
The diverging trends between Molina’s fourth quarter and annual results reveal the complexities faced by the healthcare provider. While the overall growth in premium and total revenue points to a strengthening business foundation, the fourth quarter losses raise concerns about operational efficiency and cost management.
The increase in the Medical Care Ratio suggests that Molina is experiencing higher costs associated with providing healthcare services, which could be a consequence of inflationary pressures or increased demand for medical services. The elevated G&A ratio also indicates that administrative costs have risen, which may require further scrutiny.
Looking ahead, investors and analysts will be keenly watching how Molina Healthcare addresses these challenges, particularly in managing healthcare costs while continuing to grow revenue streams. The company’s strategic initiatives in the coming quarters will be crucial for restoring profitability and investor confidence.
As the healthcare landscape continues to evolve, Molina's ability to navigate these complexities will determine its market position and financial health in the years ahead.
